RU95104171A - Agent for treatment of immunosuppression at sepsis in human and method of its treatment - Google Patents

Agent for treatment of immunosuppression at sepsis in human and method of its treatment

Info

Publication number
RU95104171A
RU95104171A RU95104171/14A RU95104171A RU95104171A RU 95104171 A RU95104171 A RU 95104171A RU 95104171/14 A RU95104171/14 A RU 95104171/14A RU 95104171 A RU95104171 A RU 95104171A RU 95104171 A RU95104171 A RU 95104171A
Authority
RU
Russia
Prior art keywords
treatment
immunosuppression
sepsis
agent
human
Prior art date
Application number
RU95104171/14A
Other languages
Russian (ru)
Other versions
RU2115428C1 (en
Inventor
Ю.Н. Цибин
М.И. Громов
Л.П. Пивоварова
Н.К. Разумова
М.Н. Тарелкина
Т.И. Масиянская
Д.М. Широков
Н.А. Бубнова
Р.В. Тонэ
С.А. Шляпников
М.Н. Смирнов
Н.Н. Хромов-Борисов
Original Assignee
Товарищество с ограниченной ответственностью "Биотех"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Товарищество с ограниченной ответственностью "Биотех" filed Critical Товарищество с ограниченной ответственностью "Биотех"
Priority to RU95104171A priority Critical patent/RU2115428C1/en
Publication of RU95104171A publication Critical patent/RU95104171A/en
Application granted granted Critical
Publication of RU2115428C1 publication Critical patent/RU2115428C1/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

FIELD: medicine, immunology. SUBSTANCE: method involves the use of the human interleukin-2 by its parenteral administration to patient. Use of the human interleukin-2 ensures to recovery activity and amount of leukocytes and other components of immune system on which active lymphocytes act. EFFECT: enhanced effectiveness of IMMUNOSUPPRESSION treatment.

Claims (1)

В качестве средства для лечения иммуносупрессии при сепсисе у человека предложено применять человеческий интерлейкин-2 (чИЛ-2). Предложен также способ лечения иммуносупрессии при сепсисе путем парентерального введения пациенту чИЛ-2. Использование чИЛ-2 позволяет восстановить активность и количество лейкоцитов, а также остальных компонентов иммунной системы, на которые воздействуют активные лимфоциты, и тем самым обеспечить эффективное лечение иммуносупрессии.It has been proposed to use human interleukin-2 (hIL-2) as an agent for the treatment of immunosuppression in sepsis in humans. A method for the treatment of immunosuppression in sepsis by parenteral administration of hIL-2 to a patient is also proposed. Using chIL-2 allows you to restore the activity and number of leukocytes, as well as other components of the immune system that are affected by active lymphocytes, and thereby provide effective treatment for immunosuppression.
RU95104171A 1995-03-28 1995-03-28 Method of treatment of human with immunosuppression at sepsis RU2115428C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU95104171A RU2115428C1 (en) 1995-03-28 1995-03-28 Method of treatment of human with immunosuppression at sepsis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU95104171A RU2115428C1 (en) 1995-03-28 1995-03-28 Method of treatment of human with immunosuppression at sepsis

Publications (2)

Publication Number Publication Date
RU95104171A true RU95104171A (en) 1997-01-20
RU2115428C1 RU2115428C1 (en) 1998-07-20

Family

ID=20165904

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95104171A RU2115428C1 (en) 1995-03-28 1995-03-28 Method of treatment of human with immunosuppression at sepsis

Country Status (1)

Country Link
RU (1) RU2115428C1 (en)

Also Published As

Publication number Publication date
RU2115428C1 (en) 1998-07-20

Similar Documents

Publication Publication Date Title
DK0702560T3 (en) Immune boosting by intermittent interleukin-2 treatment
ATE157257T1 (en) ENHANCEMENT OF SUPPRESSIVE REGULATION OF AUTOIMMUNE DISEASES BY ORAL OR ENTERAL ADMINISTRATION OF AUTOANTIGENS
CA2149329A1 (en) Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma
RU94027680A (en) Parathyroid hormone and raloxifen for bone mass increase, pharmaceutical composition and method of osseous mass increase
TW376320B (en) Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
HUP0203084A2 (en) Use of baff receptor (bcma) as an immunoregulatory agent
ATE319474T1 (en) TREATMENT OF AUTOIMMUNE DISEASES BY ORAL ADMINISTRATION OF AUTOANTIGENS
MY104069A (en) Therapeutic nucleosides
DE69512374D1 (en) COMPOSITIONS CONTAINING TROXERUTIN AS A COMPLEX WITH PHOSPHATIDYLCHOLINE FOR THE TOPICAL TREATMENT OF ERECTIONAL IMPOTENCE
RU94045825A (en) Use of material obtained from mycobacterium vaccae for production of therapeutic agent used for psychiatric disease treatment, method of psychiatric disease treatment, product containing antigenic and/or immunoregulating material, pharmaceutical agent
RU92016463A (en) APPLICATION OF DERIVATIVES OF TISSTINES FOR THE MANUFACTURE OF MEDICINES WITH IMMUNOMODING EFFECT, PHARMACEUTICAL COMPOSITIONS ON THEIR BASIS
NL970023I1 (en) Medicines for treatment of eye inflammation.
EA199800717A1 (en) METHOD FOR THE TREATMENT OF MAMMAL DISEASES AND THE CYVITTERION COMPOSITION
ATE265851T1 (en) TREATMENT OF DISEASES CAUSED BY CYTOKINE GROWTH FACTOR
RU95104171A (en) Agent for treatment of immunosuppression at sepsis in human and method of its treatment
RU94032792A (en) Application of 5htia-antagonists for tobacco use stopping
RU94046312A (en) Use of biologically active ureido-derivatives for treatment lentivirus-induced disease, products containing ureido-derivatives
IT1172264B (en) ENZYME SIMILAR TO PEPSIN FROM HUMAN LEUKOCYTE, PROCEDURE TO PREPARE IT, AND THERAPEUTIC COMPOSITION THAT CONTINUES IT AS AN ACTIVE INGREDIENT
RU95110653A (en) Agent stimulating immunoglobulin synthesis in experiment
SU721109A1 (en) Method of treating inflammatory diseases of salivary glands
RU94002713A (en) Method for treating children possessing elongated qt interval syndrome
RU93001041A (en) METHOD OF TREATMENT OF PATIENTS WITH TIGHTLY PNEUMONIA
RU94037731A (en) Method for treating multiple sclerosis
RU93058154A (en) METHOD FOR TREATING EARLY ACQUIRED FORMS OF SYPHILIS
RU94037232A (en) Peptides showing organ-protective activity, method of their synthesis and their use

Legal Events

Date Code Title Description
PD4A Correction of name of patent owner
HE4A Notice of change of address of a patent owner